The corporate development team made a passionate presentation. The deal made perfect sense on paper. The strategic logic was sound. The synergies were clearly articulated. The financial models were robust, stress-tested, and unanimously approved. Advisors and investment bankers were confident. The board was aligned. The market initially rewarded the announcement.
And yet—18 months later—the integration was faltering. Key leaders had left. Critical talent was disengaged. Decision-making slowed. Cultural fault lines emerged. The promised synergies remained elusive.
Nothing material had changed in the strategy. What had changed was the human system required to execute it.
This story is not unusual. It is, in fact, familiar to most boards and CEOs who have lived through complex mergers and acquisitions—across geographies, regulatory contexts, and operating models. Which raises a more uncomfortable question: Why do so many M&A deals fail—not at the moment of strategy, but at the point of execution?
THE PERSISTENT M&A PARADOX
Decades of failed deals tell us that a significant percentage of M&A deals underperform their stated objectives. Boards know this pattern well; it surfaces repeatedly in post-acquisition reviews, value-impairment discussions, and leadership transitions that come sooner than expected.
They always give vague reasons: cultural mismatch, integration challenges, or change fatigue. These explanations are directionally accurate—but definitely incomplete.
The deeper issue is this: M&A valuation assumes execution capacity without rigorously testing whether it exists.
Boards scrutinize deal economics with discipline. They debate multiples, model synergies, assess market overlap, and pressure-test downside scenarios. But far less time is spent examining whether the combined organization has the human capacity to deliver what the numbers promise. In other words, execution is treated as inevitable when it is anything but.
WHAT M&A MODELS ASSUME—SILENTLY
Every acquisition model embeds a set of unspoken assumptions about people:
- Leadership from both organizations will align quickly
- Key talent will stay through uncertainty
- Decision rights will be clarified without friction
- Cultural differences will reconcile under pressure
- Incentives will reinforce, rather than undermine, integration goals
These assumptions rarely appear on a diligence checklist. They rarely affect the discount rate. And yet, they determine whether synergies are realized or quietly written off.
Financial models assume execution. Human capital determines whether execution is possible.
A TALE OF TWO INTEGRATIONS
Consider two acquisitions of similar size and strategic intent. In the first, integration leadership is treated as an extension of deal management. Cultural alignment is addressed late. Leadership roles are clarified slowly. High-performing talent from the acquired company feels uncertain—and begins to leave. Synergies slip quarter by quarter, until expectations are quietly reset.
In the second, the acquiring board emphasizes early understanding of leadership depth, succession readiness, and cultural adaptability on both sides. Integration roles are staffed with credibility, not availability. Talent risks are identified explicitly. Incentives are aligned to integration outcomes, not just financial milestones.
Both deals looked identical at the announcement.
Only one delivers its full value.
The difference is not strategy.
It is a human capital discipline.
WHY BOARDS DISCOVER HUMAN CAPITAL RISK TOO LATE
Most boards believe they are managing people risk during M&A. In reality, they often discover it only after value has already been impaired.
That is because human capital is still treated as:
- A post-close integration issue
- A cultural concern rather than a valuation driver
- A leadership matter rather than a fiduciary one
This framing is outdated.
In today’s environment—where value increasingly resides in capabilities, knowledge, and leadership systems—human capital risk is execution risk, and execution risk is valuation risk.
THE HUMAN CAPITAL RISK PREMIUM IN M&A
It is time for boards to explicitly recognize what I call the human capital risk premium.
Just as valuations adjust for regulatory exposure, customer concentration, or geopolitical uncertainty, they should adjust for people-related execution risk, including:
- Leadership dependency on a few individuals
- Fragile succession pipelines
- Cultural incompatibilities under stress
- Incentive misalignment during integration
- Skill gaps critical to the combined strategy
Two deals with identical financial projections should not be valued the same if one carries materially higher human capital risk.
This is not about being conservative.
It is about being realistic.
THE QUESTIONS BOARDS SHOULD ASK—BEFORE THE DEAL CLOSES
Rather than relying on post-merger integration plans to surface risk, boards should press for answers to sharper questions before approving a transaction:
- Where does the success of this deal depend on specific individuals rather than scalable systems?
- Which roles, if vacated in the first year, would materially impair value?
- How compatible are decision-making norms—not just cultures—in moments of conflict?
- How quickly can the combined organization redeploy talent as integration realities evolve?
- What behaviors will this deal actually reward once integration pressure sets in?
The rigor of these answers should inform confidence in the deal—not merely comfort with the strategy.
WHY THIS MATTERS MORE THAN EVER
The pace of change has accelerated. Talent markets are less forgiving. Employees are more mobile. Integration timelines are compressed. And the margin for execution error is thinner.
In this environment, the traditional separation between “deal logic” and “people considerations” is no longer viable.
The transaction itself does not create enterprise value.
It is created—or destroyed—in the months that follow, by leaders, teams, and systems under pressure.
REFRAME M&A GOVERNANCE
The most important question for boards and CEOs considering an acquisition is no longer: “Is this deal strategically and financially sound?”
The question is: “Does the combined organization have the human capacity to deliver what this deal assumes?”
Until M&A valuation and governance confront that question directly, we will continue to see well-intentioned, well-modeled deals fail for entirely foreseeable reasons.
Execution is not guaranteed. And valuation models must finally reflect that reality.
Bala V. Sathyanarayanan is EVP and CHRO at Greif, and board chairman at Balmer Lawrie-Van Leer.